(Q43977414)

English

Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue

scientific article published in April 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

based on heuristic

inferred from title

7

object named as

Winblad B

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

6

object named as

Wahren B

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Zou LP

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Abbas N

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Volkmann I

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Nennesmo I

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Levi M

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Hedlund G

8

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Zhu J

9

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Neuropharmacology

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

731-739

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Molecular mimicry and the autoimmune response to the peripheral nerve myelin P0 glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Linomide-induced suppression of experimental autoimmune neuritis is associated with down-regulated macrophage functions

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Nasal administration of recombinant rat IL-4 ameliorates ongoing experimental autoimmune neuritis and inhibits demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Linomide suppresses acute experimental autoimmune encephalomyelitis in Lewis rats by counter-acting the imbalance of pro-inflammatory versus anti-inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Preceding infections, immune factors, and outcome in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Interleukin-18 is induced in acute inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Identification of the neuritogen for experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Immunomodulation of experimental autoimmune myasthenia gravis with linomide

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide: a double-blind, placebo-controlled pilot study with monthly magnetic resonance imaging evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

The Th1-Th2 paradigm in 1998: law of nature or rule with exceptions

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

P0 myelin protein produces experimental allergic neuritis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Myelination in rat brain: method of myelin isolation.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results. North American Linomide Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Changing the chemokine gradient: CINC1 crosses the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

The inhibitory effect in experimental autoimmune encephalomyelitis by the immunomodulatory drug Linomide (PNU-212616) is not mediated via release of endogenous glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

IL-10 and IFN-gamma in Guillain-Barré syndrome. Network Members of the Swedish Epidemiological Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Successful treatment of autoimmunity in MRL/1 mice with LS-2616, a new immunomodulator

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Linomide in relapsing and secondary progressive MS: part II: MRI results. MRI Analysis Center of the University of Texas-Houston, Health Science Center, and the North American Linomide Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Linomide suppresses both Th1 and Th2 cytokines in experimental autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Cellular mRNA expression of interferon-gamma, IL-4 and transforming growth factor-beta (TGF-beta) by rat mononuclear cells stimulated with peripheral nerve myelin antigens in experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Dynamics of mRNA expression of interferon-γ, interleukin 4 and transforming growth factor β1 in sciatic nerves and lymphoid organs in experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Linomide suppresses chronic-relapsing experimental autoimmune encephalomyelitis in DA rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Suppression of autoimmune neuritis in IFN-gamma receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Treatment with P2 protein peptide 57-81 by nasal route is effective in Lewis rat experimental autoimmune neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Rolipram suppresses experimental autoimmune neuritis and prevents relapses in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

Potential role of autoantibodies in the regulation of cytokine responses during bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900015-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0028-3908(02)00015-1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43977414&oldid=2105223803"